Number of marketed drugs
This presentation is the property of its rightful owner.
Sponsored Links
1 / 50

Number of marketed drugs PowerPoint PPT Presentation


  • 59 Views
  • Uploaded on
  • Presentation posted in: General

Number of marketed drugs. Source: The Norwegian Medicines Control Authority. Number of marketed drugs manufactured in Norway and abroad. The top 20 pharmaceutical companies on the Norwegian market, 1998 Sales, veterinary products excluded. The top 25 drugs in Norway, by value, 1998.

Download Presentation

Number of marketed drugs

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Number of marketed drugs

Number of marketed drugs

Source: The Norwegian Medicines Control Authority


Number of marketed drugs manufactured in norway and abroad

Number of marketed drugs manufactured in Norway and abroad


The top 20 pharmaceutical companies on the norwegian market 1998 sales veterinary products excluded

The top 20 pharmaceutical companies on the Norwegian market, 1998 Sales, veterinary products excluded


The top 25 drugs in norway by value 1998

The top 25 drugs in Norway, by value, 1998

The top 25 drugs represent 2,175 mill NOK, corresponding to approximately 35% of the total sales on pharmacy purchase level

Source: FARMASTAT


The top 10 drugs in norway by units 1998

The top 10 drugs in Norway, by units, 1998.

Number of units sold (x 1000

Product

Several products on this list are painkillers. Albyl-E is in addition to being a painkiller also used as an anticoagulant in low doses.Otrivin, Rhinox and zymelin are nasal decongestants, in cold.

Source: FARMASTAT


Sales of drugs distributed on therapeutic groups atc 1996 and 1997

Sales of drugs distributed on therapeutic groups (ATC), 1996 and 1997


Number of units of drugs sold distributed on non prescription and prescription drugs 1998

Number of units of drugs sold distributed on non-prescription and prescription drugs, 1998

65.5 million units of drugs were sold in 1998. 55% of these were prescription drugs and 45% were non-prescription drugs. 47% of all prescriptions handled in the pharmacies are reimbursable prescriptions (blue-prescriptions). There are in average more units prescribed per blue prescription in comparison with white prescriptions (non-reimbursable) - 55% of all units of prescription drugs sold are reimbursable.

Kilde/Source: Norges Apotekerforening, FARMASTAT,

The Norwegian Association of Proprietor Pharmacists, FARMASTAT


Prescription drugs percentage reimbursable 1997

Prescription drugs - percentage reimbursable, 1997

65.5 million units of drugs were sold in 1998. 55% of these were prescription drugs and 45% were non-prescription drugs. 47% of all prescriptions handled in the pharmacies are reimbursable prescriptions (blue-prescriptions). There are in average more units prescribed per blue prescription in comparison with white prescriptions (non-reimbursable) - 55% of all units of prescription drugs sold are reimbursable.

Source: The Norwegian Association of Proprietor Pharmacists, FARMASTAT


Prescription drugs percentage reimbursable 19971

Prescription drugs - percentage reimbursable, 1997

65.5 million units of drugs were sold in 1998. 55% of these were prescription drugs and 45% were non-prescription drugs. 47% of all prescriptions handled in the pharmacies are reimbursable prescriptions (blue-prescriptions). There are in average more units prescribed per blue prescription in comparison with white prescriptions (non-reimbursable) - 55% of all units of prescription drugs sold are reimbursable.

Source: The Norwegian Association of Proprietor Pharmacists, FARMASTAT


Private pharmacies composition of sales 1997

Private pharmacies’ composition of sales, 1997

Source: The Norwegian Association of Proprietor Pharmacists


Sales of drugs in norway fixed and variable prices 1980 1998

Sales of drugs in Norway, fixed and variable prices, 1980 - 1998

Source: Norwegian Board of Health and Statistics Norway


Distribution of the total drug sales pharmacy retail level

Distribution of the total drug sales. (Pharmacy retail level)

31.1% of the total drug bill is covered by the consumers.

The patients’ contribution is distributed on non-reimbursable drugs, non-prescription drugs, veterinary products and co-payment for reimbursable drugs. The diagram is made by using data from various sources and should only be used with that in mind

Source: LMI


Public health care and drug expenditure 1988 1997

Public health care and drug expenditure, 1988 - 1997

1)National Insurance and hospitals

2) % of public health care expenditure

Source: Statistics Norway and The Norwegian Board of Health


National insurance administration drug expenditure percent increase 1989 1998

National Insurance Administration drug expenditure, percent increase, 1989 - 1998

Source:National Insurance Administration


Drug expenditure in private and public sector 1989 1997 sales on pharmacy retail level

Drug expenditure in private and public sector, 1989 - 1997Sales on pharmacy retail level

Source: The Norwegian Board of Health


Drug expenditure in private and public sector 1989 1997 sales on pharmacy retail level1

Drug expenditure in private and public sector, 1989 - 1997Sales on pharmacy retail level

Source: The Norwegian Board of Health


Public drug expenditure 1997 currency

Public drug expenditure* (1997-currency)

* National insurance and hospitals

The figures are in 1997-currency (corrected by the consumer price index)

VAT in Norway was 20% until 31.12.1992. It was increased to 22% on 01.01.1993 and to 23% on 01.01.1995.

Source: The Norwegian Board of Health


Public drug expenditure percent increase excl vat 1997 currency

Public drug expenditure, percent increase, excl. VAT, (1997-currency)

Public drug expenditure: National Insurance and hospital. The increase in expenditure is calculated in 1997-currency(corrected by the consumer price index)

Source: The Norwegian Board of Health


Number of marketed drugs

The share of innovative drugs of the total sales, 1993 - 1998Sales in mill NOK, 1998-currency, on pharmacy purchase level

Source: LMI


Public health care expenditures nok per capita 1997

Public health care expenditures, NOK per capita, 1997

Source: Statistics Norway


Consumer expenditure on pharmaceuticals compared to other expenses nok per capita 1997

Consumer expenditure on pharmaceuticals compared to other expenses NOK per capita, 1997

Source: Statistics Norway and Norwegian Board of Health


Norway s import and export of pharmaceutical products 1988 1997

Norway’s import and export of pharmaceutical products, 1988 - 1997

Source: Statistics Norway, based on OECD Standard International Trade Classification (SITC) division 54


Import distributed on countries of origin 1997

Import distributed on countries of origin, 1997

Total import 1997: 4.363 mill NOK

Source:Statistics Norway, based on OECD Standard International Trade Classification (SITC) division 54


Export distributed on export countries 1997

Export distributed on export countries, 1997

Total export 1997: 1.537 mill NOK

Source:Statistics Norway, based on OECD Standard International Trade Classification (SITC) division 54


Number of marketed drugs

The Pharmaceutical Industry’s investments in research and development (R & D) in Norway, NOK million, 1995 - 1997

Source: LMI


Number of marketed drugs

The Pharmaceutical Industry’s investments in research and development (R & D) in percent of drug sales in Norway (pharmacy purchase price), 1995 - 1997

Source: LMI


Parallel imported drug sales in norway 1995 1998 pharmacy purchase price in nok million

Parallel imported drug sales in Norway, 1995 - 1998 (pharmacy purchase price in NOK million)

Percentage of drug sales0,21,43,46,9

Source: FARMASTAT


Structural effects in sales pharmacy purchase price 1989 1998

Structural effects in sales, (pharmacy purchase price), 1989-1998

Total sales increased by 10.3% in 1998 (pharmacy purchase price). The increase is caused by a price reduction of -0.9%, an increase in number of doses (change in quantity) of 5.9% and change due to new drugs of 5.3%.

Source: Norwegian Medicinal Depot


Prices on drugs divided on the distributors 1996

Prices on drugs - divided on the distributors, 1996

Prescription and non-prescription drugs.

Source: Norwegian Competition Authority


Number of marketed drugs

Price changes on drugs (pharmacy purchase price) and general inflation, annual percent increase, 1993-1998

Source: Statistics Norway, Norwegian Medicinal Depot


Leading corporate groups global performance 1996

Leading Corporate Groups, Global Performance, 1996

Source: IMS International, Pharmaceutical World Review (Presented by MEFA in Facts, 1997)


Leading products world wide 1996

Leading products world-wide, 1996

Source: Scrip Magazine, 1998 (Presented by LIF in Facts, 1998)


Price level on drugs in some european countries 1998 norway 100

Price level on drugs in some European countries, 1998Norway = 100

The price index is calculated from pharmacy purchase prices and Swedish volumes in 1997, and exchange rates per 2.1.98. The pharmacy purchase prices are from each country’s pharmacy price lists.

Source.: Apoteket AB, Sweden. (The figures are calculated to Norway = 100)


Pharmaceutical consumption per capita in europe 1997

Pharmaceutical consumption per capita in Europe, 1997

The figures are calculated on the basis of sources, using methods specific to each country. Strict comparisons between countries may therefore not be reliable.

Source: EFPIA


Number of marketed drugs

Health expenditure in OECD-countries, 1996Totale helseutgifter i % av BNP / Total health expenditure in % of GDP

1994 -figures: Turkey

GDP: Gross Domestic Product

The figure for Norway in the above diagram is different from the ones presented on page 15 due to different data sources.

Source: OECD in figures, 1998


Public drug expenditure in percent of public healthcare expenses in some european countries 1997

Public drug expenditure in percent of public healthcare expenses in some European countries, 1997

Source: EFPIA


Composition of consumer prices of medicine in europe pharmacy retail price 1996

Composition of consumer prices (%) of medicine in Europe (pharmacy retail price), 1996

Source: EFPIA (presented by LIF in Facts, 1998)


Number of marketed drugs

Composition of consumer prices (%) of medicine in Europe (pharmacy retail price), 1996 Page 2

1. The ”official” wholesaler’s margin is 12,5%, but of this 7,5 % is passed on to the Pharmacists as incentive bonus.

VAT; Zero on prescrption medicines and 17,5 % on OTC.

2. VAT on OTC are 25 % and no VAT on prescription drugs.

3. VAT on OTC are 5 %

4. Prescription only medicine.

5. Prices are on oral medicine only

6. 1997- figures

7. Reimburable medicine.

8. Local manufactures only. Other taxes (13,0 %), besides VAT (7,4 %)

9. VAT and Pharmacy fee.


Vat on drugs and other products and services in europe 1999

VAT on drugs and other products and services in Europe, 1999

VAT RATES APPLIED TO MEDICINES PER FEBRUARY 1, 1999

1)FRANCE: Reimbursable medicines 2.1%. Non-reimbursable medicines 5.5%

2) IRELAND: Oral medication 0%, other medication 21%

3)AUSTRIA: 0% for medicines covered by health insurance

Source: EFPIA


The most common causes of death 1995

The most common causes of death, 1995

Source: Statistics Norway


Disablement pensions according to diagnosis 1997

Disablement pensions according to diagnosis, 1997

Total number of disablement pensions per December 1997: 246 541

Source: National Insurance Administration


Expenditures of the national insurance nok billion 1998

Expenditures of the National Insurance (NOK billion), 1998

Source: National Insurance Administration


Expenditures of the national insurance

Expenditures of the National Insurance

National Insurance Administration’s expenditures in 1998: NOK 150 355 millions

Source: National Insurance Administration


Operating costs at the largest hospital in norway ullev l hospital in 1996 and 1997 percent share

Operating costs at the largest hospital in Norway, (Ullevål hospital) in 1996 and 1997 (percent share)

Source: Ullevål Hospital


Prescription statistics 1997 reimbursable drugs distribution of sales on reimbursement groups

Prescription statistics, 1997. Reimbursable drugs, distribution of sales on reimbursement groups

Calculated on the basis of sales from a selection of pharmacies

Source:The Norwegian Association of Proprietor Pharmacists


Key figures for hospital admissions

Key figures for hospital admissions


Key figures for hospital admissions1

Key figures for hospital admissions

Source: Statistics Norway


Key figures for hospital admissions2

Key figures for hospital admissions


Inhabitants per physician and per dentist 1994 1998

Inhabitants per physician and per dentist, 1994 - 1998

Source: The Norwegian Board of Helth and Statistics Norway


Inhabitants per pharmacy 1994 1998

Inhabitants per pharmacy, 1994 - 1998

Source: The Norwegian Board of Health and Statistics Norway


  • Login